Michigan-based Zomedica, a relatively new company focused on developing pet meds and complementary products, this week reeled in C$5 million ($4 million) as the first part of a share placement offering.
5AM Ventures, the prolific biotech and drug delivery investor out of Menlo Park, CA, has raked in $285 million for its fifth fund, according to an SEC filing.
AbSci, which manufactures soluble microbial proteins, said it secured $5.1 million in a round of Series A financing that it plans to use to speed up commercialization of its protein expression platform used in biopharmaceutical manufacturing.
